The CDC NPIN Featured Partner resource offers HIV/AIDS, viral hepatitis, STD, and TB prevention-focused organizations a platform to showcase their services, programs, and materials. Our goal is to highlight the work of CDC's prevention partners and encourage partners to connect with each other to share information and strategies. Organizations are nominated by CDC or their peers, or are self-nominated. Those selected are featured on the NPIN Web site for the month.
National Jewish Health opened its doors in 1899 as the nation’s first institution with the primary goal of treating indigent tuberculosis (TB) victims, and until 1969, it did not charge for its services. It has a long history as a resource for the diagnosis and treatment of refractory mycobacterial infections, including drug-resistant TB and nontuberculous mycobacterial infections. Over the last 111 years, the National Jewish Health Division of Mycobacterial and Respiratory Infections has made milestone contributions to TB patient care and research that are used around the world:
- Testing anti-TB drugs.
- Developing proper dosage measurements.
- Creating effective treatment protocols, including combined pharmacotherapies.
- Building and maintaining a world-class pharmacokinetics laboratory to identify patient-specific information about metabolism and medication blood levels.
- Offering the Mycobacteriology Consult Line, email@example.com, to provide healthcare professionals with recommendations about appropriate drug therapy, duration of therapy, patient isolation, information about surgical intervention, recommendations on monitoring drug toxicity, and referral information. This service is free of charge to providers across the country.
The award-winning National Jewish Health LungLine® at 800222LUNG or firstname.lastname@example.org is another free service available to healthcare consumers. The LungLine offers consumers the opportunity to talk with respiratory nurses about TB and other lung and lung-related diseases.
The National Jewish Health Division of Mycobacterial and Respiratory Infections offers diagnostic, therapeutic, and consultative services for all infectious diseases, including nontuberculous mycobacterial infections and other respiratory pathogens. All levels of disease severity can be treated either with an inpatient unit that meets the strict environmental infection controls for multidrug-resistant disease and/or intensive outpatient care similar to an inpatient experience.
National Jewish Health also has an HIV Clinical and Research Program and is currently accepting new patients, with a focus on long-term healthcare.
Molly Blank Conference Center at National Jewish Health, where the Denver TB Course will be held
Education has always been part of the mission at National Jewish Health. In 1963, the institution started the Denver TB Course, the longest running course in the United States for nurses and physicians on TB and TB-related topics. Speakers who participate in the 3-and-a-half-day course are internationally respected leaders in the field of TB. On the first day, the emphasis is on the history, epidemiology, immunopathogenesis, and microbiology of the organism. The second day’s focus is on the diagnosis and treatment of latent, active, and drug-resistant TB. The last portion of the course features the unique presentations of TB, including pediatric, extrapulmonary, and HIV-related infection. Other highlights include a workshop on contact investigation, infection control, and the management of nontuberculous mycobacterial infections.
Prevention of further TB cases can only occur with a strong foundation of knowledge on the part of the medical provider. The essential components for a successful TB control program include identifying and treating persons with active disease, effective contact investigation, and screening for and treating latent TB infection when appropriate. The Denver TB Course focuses on these essential components to train public health providers across the country.
The Denver TB Course educates providers and new generations of mycobacterial
experts who will be responsible for the management and care of TB in the future. It is offered
annually in April and October. Visit the TB Course Web site for registration information.
Contact the NPIN Outreach Team for more information on Featured Partner nominations—email@example.com
Visit the Featured Partner Archive to learn about other Featured Partners.